HOME >> BIOLOGY >> NEWS
Charting the future in prostate cancer care: A call to action

LOS ANGELES, Sept. 9 -- This year, an estimated 230,000 men will be diagnosed with prostate cancer in the United States, and 30,000 are expected to die from the disease. Today, about two million men are battling prostate cancer, and over the next decade, about three million more will be compelled to join the war. The need for new therapies is great, and since 1993, The Prostate Cancer Foundation has played a pivotal role in supporting and funding R&D breakthroughs to defeat this disease.

The timing is becoming ever more critical. As the baby boomer men reach the target age for prostate cancer, beginning at age 50, this disease will become the cancer with the greatest increase in incidence, in addition to being the most common non-skin cancer in the U.S. In fact, over the next decade, the number of new prostate cancer cases in the U.S. is expected to increase by 50 percent to more than 300,000 new cases per year. Unfortunately, even today, prostate cancer treatment and research has lagged behind other areas, such as that of breast cancer, where there has been recent progress in integration among specialties and late-stage innovation of new therapeutics.

On September 22, 2004, the Prostate Cancer Foundation (PCF) will release its Report to the Nation on Prostate Cancer, authored by 24 leading prostate cancer experts. A distinguished panel will present the major findings of the Report and its authors' calls to action to address the urgent need to improve the management of prostate cancer and accelerate the development of better treatments and a cure. The PCF will also debut a public service announcement campaign "It's a TEAM Approach: Prostate Cancer Treatment, Education, Awareness and Management". The PSA features golf legend Arnold Palmer, a prostate cancer survivor, who encourages a multi-disciplinary team approach to this deadly disease, which affects one in six men in their lifetime.

Who: Panelists and Special Gues
'"/>

Contact: Justin Jackson
jjackson@burnsmc.com
212-213-0006
Burns McClellan
9-Sep-2004


Page: 1 2 3

Related biology news :

1. Lights, Camera ... Reaction: Charting The Biological Effects Of Light InBillionths Of A Second
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. Sandia experiments may reduce possibility of future water wars
4. Will a reduction in military spending improve our environmental future?
5. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
6. Engineering endurance: The future of the Olympics?
7. The future of nanotechnology
8. Chemoradioimmunotherapy for advanced breast cancer: hope for the future?
9. Endometriosis: Could angiostatic therapy be the new treatment of the future?
10. Plants for the future: A European vision for plant biotechnology towards 2025
11. Plant pathologists to discuss the future of organic farming

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... N.J. , Jan. 11, 2017  Michael Johnson, co-founder of ... Venture Capital Group, Inc., has been named to the elite "Forbes ... 27,  was one of 600 people in 20 fields nationwide to ... percent of the 15,000 applicants were selected. ... He is currently a PhD candidate at ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... 19, 2017 , ... November Research Group, LLC, a global ... device manufacturers and regulators, is proud to announce the worldwide release of PRIMO ... to provide product vigilance departments with the flexibility and ease of use of ...
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
(Date:1/19/2017)... Island, NY (PRWEB) , ... January 19, 2017 , ... ... at an exponential rate. The tremendous growth is accounted to two main factors. ... the table and the expanding network of vendors supplying FireflySci products all around the ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
Breaking Biology Technology:
Cached News: